Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Solena Ag is an agricultural biotechnology and software company focused on soil microbiome analysis, regenerative agriculture, and AI-driven crop input recommendations. The company aggregates microbiome, climate, crop, and soil data to measure "biological capital," detect soil risks, and generate tailored prescriptions intended to improve yield, reduce synthetic input use, and support sustainability outcomes. Its core platform, Prometheus, appears to function as a soil intelligence and decision-support system rather than a therapeutic development platform. Solena also offers soil health scoring, pathogen detection, biomarker analysis, API-based integrations, and programs tied to regenerative agriculture and crop financing. Based on currently available information, Solena is an active private company operating commercially across multiple countries, but it is not a human healthcare, biotech drug, or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Solena Ag.